Back
Description
From unevenness to persistent dark spots: MELA B3 serum is the new anti-dark spots serum powered by multi-patented Melasyl™ & 10% Niacinamide to help correct the look of dark spots, even persistent ones.
Hyperpigmentation Innovation: new multi-patented Melasyl™ active. Fight Hyperpigmentation. A new mode of action, like never before. Intercepts excess melanin at a different stage of its production before it marks the skin.
Dark Spots Clinically Reduced for 94%*
*50 subjects, instrumental measurement of size of overall area of dark spots after 12 weeks.
WHAT IT IS:
An anti-hyperpigmentation serum that corrects the appearance of dark spots. Co-developed with leading dermatologists and pigmentation experts, MELA B3 combines new multi-patented Melasyl™ ingredient- our active melanin trapper- with 10% Niacinamide (also known as Vitamin B3) for a multi-action against hyperpigmentation that also soothes skin & strengthens the skin barrier. Acts to lighten the appearance of existing pigmentation whilst helping prevent the appearance of future dark spot discolouration. Helps even skin’s tone with an ultra-sensorial lightweight gel-serum texture. Anti-recurrence.
DERMATOLOGICALLY TESTED:
This active serum has been through testing under dermatological control. It is non-comedogenic and is also suitable for use for those who may be prone to pigmentations caused by external factors such as sun, age, post-acne marks.
RECOMMENDED BY DERMATOLOGISTS:
La Roche-Posay is the No. 1 Dermatologist recommended brand in the UK** **Study of 73 Consultant Dermatologists Jan-April 2023.
Key Benefits:
Anti-Hyperpigmentation: dark spots, post-acne marks and coloured pigmentation marks appear reduced
Hydrating formula. Hypoallergenic, alcohol-free. Non comedogenic. Dermatologically tested.
New Melasyl™ active ingredient: Fights Hyperpigmentation. A new mode of action, like never before; intercepts excess melanin at a different stage of its production before it marks the skin.
Peach-coloured gel-serum formula: light to touch & high skin affinity for fast absorption and no stickiness.
Anti-Post-Acne Marks & PIH (Post-Inflammatory Hyperpigmentation): Fades appearance of stubborn marks and gives a more even skin tone appearance.
Moisturising and soothing action. Also suitable for those who may be prone to pigmentations caused by external factors such as sun, age, post-acne marks.
Suitable for sensitive skin.
Suitable for
All Skin Types
How to use
Apply 3-4 drops morning and/or evening to face, neck & décolleté after cleansing. Always complete morning routine with daily SPF.
To maximise hyperpigmentation efficacy, use alongside the
Anthelios UVMune 400 Anti-dark Spots SPF50+ fluid.
How To
HOW TO USE:
Apply 3-4 drops morning and/or evening to face, neck & décolleté after cleansing. Always complete morning routine with daily SPF.
Ask for more information about this product
Ingredients
2039125 10 - INGREDIENTS: AQUA / WATER / EAU • DIMETHICONE • NIACINAMIDE • GLYCERIN • PROPYLENE GLYCOL • POLYSILICONE-11 • SILICA • BIS-PEG/PPG-16/16 PEG/PPG-16/16 DIMETHICONE • CYSTOSEIRA TAMARISCIFOLIA EXTRACT • 2-MERCAPTONICOTINOYL GLYCINE • PEG-20 METHYL GLUCOSE SESQUISTEARATE • SODIUM HYALURONATE • SODIUM HYDROXIDE • SODIUM THIOSULFATE • CARNOSINE • POLOXAMER 338 • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • DIPOTASSIUM GLYCYRRHIZATE • CAPRYLIC/CAPRIC TRIGLYCERIDE • CAPRYLOYL SALICYLIC ACID • CAPRYLYL GLYCOL • CITRIC ACID • TRISODIUM ETHYLENEDIAMINE DISUCCINATE • XANTHAN GUM • PENTYLENE GLYCOL • OCTYLDODECANOL • RETINYL PALMITATE • TOCOPHEROL • PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE • PHENOXYETHANOL • CI 17200 / RED 33 • PARFUM / FRAGRANCE (F.I.L. N70037312/1).
Ratings & Reviews
MELA B3 HYPERPIGMENTATION SERUM 30ML Product code : 3337875890021
La Roche Posay - MELA B3
MELA B3 SERUM: Intense Anti-dark spot serum for hyperpigmentation
Clinically tested on dark spot prone skin. Clinically proved to help correct hyperpigmentation .
Dark Spots Clinically Reduced for 94%*
*50 subjects, instrumental measurement of size of overall area of dark spots after 12 weeks.
Read less
